Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Insmed (INSM) Long-Term Debt Issuances (2016 - 2022)

Insmed's Long-Term Debt Issuances history spans 5 years, with the latest figure at $350.0 million for Q4 2022.

Quarterly Long-Term Debt Issuances rose 160.87% to $350.0 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$225.0 million through Dec 2022, up 60.87% year-over-year, with the annual reading at $150.0 million for FY2024, N/A changed from the prior year.
Long-Term Debt Issuances came in at $350.0 million for Q4 2022, up from -$575.0 million in the prior quarter.
In the past five years, Long-Term Debt Issuances ranged from a high of $450.0 million in Q1 2018 to a low of -$575.0 million in Q4 2021.
The 3-year median for Long-Term Debt Issuances is $350.0 million (2022), against an average of $75.0 million.
The largest YoY upside for Long-Term Debt Issuances was 160.87% in 2022 against a maximum downside of 160.87% in 2022.
Insmed's Long-Term Debt Issuances stood at $450.0 million in 2018, then tumbled by 227.78% to -$575.0 million in 2021, then surged by 160.87% to $350.0 million in 2022.
Per Business Quant, the three most recent readings for INSM's Long-Term Debt Issuances are $350.0 million (Q4 2022), -$575.0 million (Q4 2021), and $450.0 million (Q1 2018).